AMD may be transformed into pancreatic intraepithelial lesions (PanINs) in the progress of activating Kras mutations or persistent epidermal growth factor receptor (EGF-R) signaling, eventually leading to the occurrence of pancreatic cancer. Here, EGFR is linked to pancreatic neoplasm.